Virtus ETF Advisers LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$116,000
-29.7%
57,437
-5.6%
0.05%
-16.1%
Q4 2021$165,000
+1.9%
60,836
+67.1%
0.06%
-12.7%
Q3 2021$162,000
-27.0%
36,410
-4.9%
0.07%
-22.0%
Q2 2021$222,000
-56.0%
38,303
-55.7%
0.09%
-65.5%
Q3 2020$504,000
-5.6%
86,459
+9.2%
0.26%
+4.3%
Q2 2020$534,000
+83.5%
79,177
+73.0%
0.25%
+110.8%
Q1 2020$291,000
-43.7%
45,754
-7.8%
0.12%
+41.2%
Q4 2019$517,000
+146.2%
49,615
-7.3%
0.08%
+102.4%
Q3 2019$210,000
-77.4%
53,505
-14.4%
0.04%
-78.6%
Q2 2019$930,000
+67.6%
62,509
+102.5%
0.20%
+106.3%
Q4 2018$555,000
+10.6%
30,876
+80.6%
0.10%
+82.7%
Q3 2018$502,000
-30.7%
17,101
+7.4%
0.05%
-91.9%
Q2 2018$724,000
-2.8%
15,930
+13.0%
0.64%
-0.9%
Q1 2018$745,000
-26.6%
14,103
-5.5%
0.65%
-49.3%
Q4 2017$1,015,000
-24.6%
14,929
-8.7%
1.27%
+600.0%
Q3 2017$1,347,000
-12.0%
16,3490.0%0.18%
-20.5%
Q2 2017$1,531,000
+208.7%
16,349
+109.7%
0.23%
+160.2%
Q1 2017$496,000
+58.5%
7,797
+10.5%
0.09%
-5.4%
Q4 2016$313,000
-51.4%
7,054
-60.5%
0.09%
-70.1%
Q3 2016$644,000
+162.9%
17,8650.0%0.31%
+70.9%
Q2 2016$245,000
+70.1%
17,865
+137.4%
0.18%
-8.1%
Q1 2016$144,000
-48.6%
7,526
-5.9%
0.20%
-74.3%
Q4 2015$280,0007,9990.77%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders